VERISMO THERAPEUTICS Trademark

Trademark Overview


On Tuesday, July 11, 2023, a trademark application was filed for VERISMO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VERISMO THERAPEUTICS trademark a serial number of 98079556. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, October 29, 2024. This trademark is owned by Verismo Therapeutics Inc.. The VERISMO THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

anti-cancer preparations; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer for use in Chimeric Antigen Receptor (CAR) T-Cell Therapy; pharmaceutical preparations for the suppression and treatment of tumors

pharmaceutical research services; research and development of pharmaceuticals for the treatment of cancer; laboratory research services relating to pharmaceuticals; medical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer
verismo therapeutics

General Information


Serial Number98079556
Word MarkVERISMO THERAPEUTICS
Filing DateTuesday, July 11, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesanti-cancer preparations; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer for use in Chimeric Antigen Receptor (CAR) T-Cell Therapy; pharmaceutical preparations for the suppression and treatment of tumors
NOT AVAILABLETHERAPEUTICS
Goods and Servicespharmaceutical research services; research and development of pharmaceuticals for the treatment of cancer; laboratory research services relating to pharmaceuticals; medical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 9, 2023
Primary Code042
First Use Anywhere DateMonday, November 30, 2020
First Use In Commerce DateMonday, November 30, 2020

Trademark Owner History


Party NameVerismo Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events


Event DateEvent Description
Friday, July 14, 2023NEW APPLICATION ENTERED
Wednesday, August 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 20, 2024ASSIGNED TO EXAMINER
Thursday, June 20, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, September 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 20, 2024NON-FINAL ACTION WRITTEN
Wednesday, March 20, 2024NON-FINAL ACTION E-MAILED
Wednesday, March 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 20, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, September 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 29, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 29, 2024FINAL REFUSAL WRITTEN
Tuesday, October 29, 2024FINAL REFUSAL E-MAILED